CDW Corp. Forecast, price target & analysts
CDW Corp. Target price 2025 - Analyst rating & recommendation
CDW Corp. Classifications & Recommendation:
CDW Corp. Price Target
| Target Price | $227.70 |
| Price | $162.08 |
| Potential | 40.49% |
| Number of Estimates | 10 |
| 10 Analysts have issued a price target CDW Corp. 2026 . The average CDW Corp. target price is $227.70. This is 40.49% higher than the current stock price. The highest price target is $250.00 54.24% , the lowest is $201.00 24.01% . | |
| A rating was issued by 14 analysts: 8 Analysts recommend CDW Corp. to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the CDW Corp. stock has an average upside potential 2026 of 40.49% . Most analysts recommend the CDW Corp. stock at Purchase. |
Sales and Margin forecast 2025, 2026 & 2027
10 Analysts have issued a sales forecast CDW Corp. 2025 . The average CDW Corp. sales estimate is $21.6b . This is 3.02% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $22.1b 5.29% , the lowest is $21.3b 1.24% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $21.0b | 1.77% |
|---|---|---|
| 2025 | $21.6b | 3.02% |
| 2026 | $22.7b | 4.91% |
| 2027 | $24.3b | 7.22% |
7 Analysts have issued an CDW Corp. EBITDA forecast 2025. The average CDW Corp. EBITDA estimate is $2.1b . This is 12.39% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $2.5b 28.66% , the lowest is $2.0b 4.43% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $1.9b | 2.83% |
|---|---|---|
| 2025 | $2.1b | 10.56% |
| 2026 | $2.3b | 6.28% |
| 2027 | $2.4b | 6.02% |
EBITDA Margin
| 2024 | 9.23% | 1.08% |
|---|---|---|
| 2025 | 9.91% | 7.35% |
| 2026 | 10.04% | 1.31% |
| 2027 | 9.92% | 1.20% |
7 CDW Corp. Analysts have issued a net profit forecast 2025. The average CDW Corp. net profit estimate is $1.1b . This is 7.26% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.3b 23.59% , the lowest is $1.1b 0.75% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $1.1b | 1.60% |
|---|---|---|
| 2025 | $1.1b | 7.26% |
| 2026 | $1.2b | 8.30% |
| 2027 | $1.3b | 8.60% |
Net Margin
| 2024 | 5.03% | 0.16% |
|---|---|---|
| 2025 | 5.24% | 4.12% |
| 2026 | 5.41% | 3.24% |
| 2027 | 5.48% | 1.29% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
7 Analysts have issued a CDW Corp. forecast for earnings per share. The average CDW Corp. EPS is $8.55 . This is 7.28% higher than earnings per share in the financial year 2024. The highest EPS forecast is $9.85 23.59% , the lowest is $8.03 0.75% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $7.97 | 1.60% |
|---|---|---|
| 2025 | $8.55 | 7.28% |
| 2026 | $9.26 | 8.30% |
| 2027 | $10.05 | 8.53% |
P/E ratio
| Current | 20.33 | 35.58% |
|---|---|---|
| 2025 | 18.96 | 6.74% |
| 2026 | 17.51 | 7.65% |
| 2027 | 16.12 | 7.94% |
Based on analysts' sales estimates for 2025, the CDW Corp. stock is valued at an EV/Sales of 1.25 and an P/S ratio of 0.99 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 1.29 | 31.02% |
|---|---|---|
| 2025 | 1.25 | 2.76% |
| 2026 | 1.20 | 4.68% |
| 2027 | 1.12 | 6.73% |
P/S ratio
| Current | 1.02 | 36.33% |
|---|---|---|
| 2025 | 0.99 | 2.92% |
| 2026 | 0.95 | 4.68% |
| 2027 | 0.88 | 6.73% |
Current CDW Corp. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Feb 06 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Feb 06 2025 |
| UBS |
Buy
➜
Buy
|
Unchanged | Jan 07 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Dec 16 2024 |
| Redburn Atlantic |
➜
Buy
|
Initiated | Nov 15 2024 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 31 2024 |
| JP Morgan |
Overweight
➜
Neutral
|
Downgrade | Oct 28 2024 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Feb 06 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Feb 06 2025 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Jan 07 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Dec 16 2024 |
|
Initiated
Redburn Atlantic:
➜
Buy
|
Nov 15 2024 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 31 2024 |
|
Downgrade
JP Morgan:
Overweight
➜
Neutral
|
Oct 28 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
